SCHEMBL5708352

SCHEMBL5708352

CC(C)(N)Cc1ccc(N)cc1.[Pd]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.64
HTR2A P28223 1/20 0.64
SLC6A4 P31645 1/20 0.64
HRH1 P35367 1/20 0.64
HTR2B P41595 1/20 0.64
CHRNA4 P43681 1/20 0.64
SLC6A3 Q01959 1/20 0.64
TAAR1 Q96RJ0 1/20 0.62
GFER P55789 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.46
FDPS P14324 1/20 0.42
MAOB P27338 4/20 0.41
MAOA P21397 2/20 0.41
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL228926 0.97 SLC6A2 (0.67) SLC6A2HTR2ASLC6A4HRH1HTR2B
Hydrochloric Acid SCHEMBL5831539 0.95 SLC6A2 (0.64) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL5079223 0.82 GFER (0.50) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL10875275 0.81 HTR2A (0.59) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL10891421 0.80 SLC6A2 (0.64) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL562858 0.80 SLC6A2 (0.64) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL564834 0.79 SLC6A2 (0.63) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL22591635 0.79 ALDH1A1 (0.52) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL861221 0.79 ESR1 (0.61) SLC6A2HTR2ASLC6A4HRH1HTR2B
SCHEMBL25342534 0.78 SLC6A2 (0.61) SLC6A2HTR2ASLC6A4HRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706371-A1 ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS Theravance, Inc. (US) 2006-10-04 EP disclosed
WO-2005070872-A1 ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS THERAVANCE, INC. (US) 2005-08-04 WO disclosed